Integrin alphavbeta6-targeted radionuclide therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Integrin alphavbeta6-targeted radionuclide therapy, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 [Phase 1]